Dr. Ruozheng Wang 王若峥
Chief Physician, Associate Professor
Department of Head and Neck Radiation Oncology, Affiliated Cancer Hospital of Xinjiang Medical University, Urumqi
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Radiotherapy for head and neck tumors, including stereotactic X-knife, 3D conformal radiotherapy, and intensity-modulated radiotherapy.
Dr. Wang is Chief Physician and Associate Professor at the Affiliated Cancer Hospital of Xinjiang Medical University, leading the Head and Neck Radiotherapy Department. With 20 years of experience, Dr. Wang completed specialist training at Fudan University Shanghai Cancer Center. Research focuses on comprehensive radiotherapy, with involvement in national and provincial fund projects and awards for research on leukemia and lymphoma treatments.
Professional roles
- Member, Chinese Medical Association
- Youth Committee Member, Chinese Society of Radiation Oncology
- Chair, Xinjiang Radiotherapy Quality Control Center
- Editorial Board Member, Chinese Journal of Modern Otorhinolaryngology
Name order: in Chinese the family name comes first (Wang Ruozheng). Papers usually list the name as Ruozheng Wang or Wang R.
Selected publications
61 papers on PubMed matched by name and affiliation; 29 as first or senior author since 2016. Most recent first- or senior-author papers:
- J Gastrointest Oncol, 2026 (senior author): FANCI promotes esophageal squamous cell carcinoma progression and cell cycle regulation and interacts with FANCD2. PubMed 42703308
- Int Immunopharmacol, 2026 (senior author): SPP1 enhances radiotherapy resistance through CCL2-mediated M2-like polarization of macrophages in cervical Cancer. PubMed 41558296
- Zhongguo Fei Ai Za Zhi, 2025 (senior author): [Expression Characteristics and Prognostic Study of PPP1R13L in Brain Metastases of Lung Adenocarcinoma]. PubMed 41622929
- Chin Med J (Engl), 2025 (senior author): Single-cell analysis identifies PI3+S100A7+keratinocytes in early cervical squamous cell carcinoma with HPV infection. PubMed 40947786
- Sci Rep, 2025 (senior author): Role of T cell exhaustion and tissue-resident memory T cells in the expression and prognosis of colorectal cancer. PubMed 40764738
- Sci Rep, 2025 (senior author): Modulation of the tumor immune microenvironment by Interferon Regulatory Factor 8 enhances immunotherapy in lung adenocarcinoma. PubMed 40113982
- Transl Oncol, 2024 (senior author): Unraveling the mechanisms of RECQL4-mediated cervical cancer progression through the PI3K/AKT pathway. PubMed 39378549
- Front Oncol, 2024 (senior author): Radiomics-based machine learning models for differentiating pathological subtypes in cervical cancer: a multicenter study. PubMed 39355130
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion